ArticleExperimental & molecular medicine2025

ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease.

Lilin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.